Humana Inc. (HUM)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 4 |
Ownership rank: | 127 |
% of all portfolios: | 0.117% |
Hold Price * : | $316.74 |
History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
Q3  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 3.30% | 6,322 | 0.04 | |
≡ | Dodge & Cox | Add 14.78% | 425,844 | 0.12 | |
≡ | Richard Pzena - Hancock Classic Value | Add 8.00% | 8,396 | 0.22 | |
Q2  2024 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 41.03% | 55,733 | 0.40 | |
≡ | Christopher Davis - Davis Advisors | Add 16.14% | 321,233 | 0.68 | |
≡ | Dodge & Cox | Buy | 2,880,956 | 1.01 | |
≡ | Richard Pzena - Hancock Classic Value | Add 81.86% | 47,215 | 1.53 | |
≡ | Seth Klarman - Baupost Group | Buy | 420,000 | 4.44 | |
Q1  2024 | |||||
≡ | Viking Global Investors | Buy | 464,130 | 0.60 | |
≡ | Richard Pzena - Hancock Classic Value | Buy | 57,680 | 1.18 | |
≡ | Christopher Davis - Davis Advisors | Add 4468.39% | 1,946,566 | 3.79 | |
Q4  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 53.10% | 82,423 | 0.78 | |
Q3  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 28.25% | 34,188 | 0.39 | |
Q2  2023 | |||||
≡ | Christopher Davis - Davis Advisors | Add 0.05% | 21 | 0.00 | |
≡ | Lee Ainslie - Maverick Capital | Add 12521.48% | 120,081 | 1.14 | |
Q1  2023 | |||||
≡ | Christopher Davis - Davis Advisors | Add 0.30% | 132 | 0.00 | |
Q2  2022 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 34.56% | 83,020 | 0.97 | |
Q4  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 0.87% | 2,191 | 0.01 | |
Q3  2021 | |||||
≡ | Bill Nygren - Oakmark Select Fund | Add 47.32% | 150,000 | 1.17 | |
≡ | Viking Global Investors | Add 411.17% | 2,418,848 | 2.62 | |
Q2  2021 | |||||
≡ | Viking Global Investors | Buy | 588,285 | 0.79 | |
Q1  2021 | |||||
≡ | Christopher Davis - Davis Advisors | Add 0.02% | 12 | 0.00 | |
≡ | Bill Nygren - Oakmark Select Fund | Buy | 317,000 | 2.85 | |
Q4  2020 | |||||
≡ | Christopher Davis - Davis Advisors | Add 1.18% | 742 | 0.00 | |
Q2  2020 | |||||
≡ | Stephen Mandel - Lone Pine Capital | Add 12.01% | 259,953 | 0.52 | |
Q1  2020 | |||||
≡ | Stephen Mandel - Lone Pine Capital | Add 46.94% | 691,296 | 1.32 | |
≡ | Lee Ainslie - Maverick Capital | Add 101.99% | 475,055 | 3.15 | |
Q4  2019 | |||||
≡ | Viking Global Investors | Buy | 103,638 | 0.18 | |
Q3  2019 | |||||
≡ | Stephen Mandel - Lone Pine Capital | Buy | 1,588,743 | 2.39 | |
Q2  2019 | |||||
≡ | David Tepper - Appaloosa Management | Buy | 95,391 | 1.13 | |
≡ | Lee Ainslie - Maverick Capital | Add 150.95% | 932,778 | 3.59 | |
Q1  2019 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 617,948 | 2.18 | |
Q2  2018 | |||||
≡ | Leon Cooperman | Add 38.82% | 51,800 | 0.54 | |
Q1  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 23.98% | 8,730 | 0.03 | |
Q4  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 71.75% | 15,210 | 0.05 | |
≡ | Leon Cooperman | Buy | 171,353 | 1.61 | |
Q3  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 27.63% | 4,590 | 0.02 | |
Q2  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 16,610 | 0.05 | |
Q1  2017 | |||||
≡ | Leon Cooperman | Buy | 125,000 | 1.04 | |
≡ | Stephen Mandel - Lone Pine Capital | Buy | 1,184,119 | 1.28 | |
Q4  2016 | |||||
≡ | Daniel Loeb - Third Point | Add 71.43% | 1,000,000 | 2.00 | |
Q3  2016 | |||||
≡ | Daniel Loeb - Third Point | Buy | 1,400,000 | 2.15 | |
Q1  2016 | |||||
≡ | David Einhorn - Greenlight Capital | Add 6.75% | 24,300 | 0.08 | |
Q4  2015 | |||||
≡ | David Einhorn - Greenlight Capital | Buy | 360,000 | 1.20 | |
Q1  2015 | |||||
≡ | Leon Cooperman | Buy | 593,400 | 1.72 | |
Q3  2014 | |||||
≡ | Stephen Mandel - Lone Pine Capital | Buy | 2,174,122 | 1.13 | |
Q2  2014 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 771,168 | 1.55 | |
Q4  2013 | |||||
≡ | Meridian Contrarian Fund | Add 10.42% | 14,000 | 0.19 | |
Q3  2013 | |||||
≡ | Meridian Contrarian Fund | Add 13.52% | 16,000 | 0.21 | |
Q2  2013 | |||||
≡ | Meridian Contrarian Fund | Add 115.09% | 63,300 | 0.80 | |
Q1  2013 | |||||
≡ | Meridian Contrarian Fund | Buy | 55,000 | 0.57 | |
Q2  2012 | |||||
≡ | David Einhorn - Greenlight Capital | Buy | 1,645,000 | 2.15 | |
Q4  2009 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Add 23.86% | 2,623,900 | 1.41 | |
Q3  2009 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Add 41.10% | 3,203,600 | 1.58 | |
Q2  2009 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Add 8.89% | 636,300 | 0.33 | |
Q4  2008 | |||||
≡ | Bruce Berkowitz - Fairholme Capital | Buy | 7,563,500 | 4.34 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.